Comparison · NCT02798354-17b6241d
Intervention Group vs Control Group: Number of Patients With Abnormal Laboratory Results With Appropriate Actions Without Delay
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Intervention Group vs Control Group: Number of Patients With Abnormal Laboratory Results With Appropriate Actions Without Delay. Trial comparisons, record NCT02798354-17b6241d. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02798354-17b6241d
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.932 | 0.918 | 0.944 | wilson | |
| Risk in group 2 | 0.938 | 0.924 | 0.95 | wilson | |
| Risk difference, group 1 minus group 2 | -0.00612 | -0.0245 | 0.0124 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.993 | 0.974 | 1.01 | log | |
| Odds ratio, group 1 over group 2 | 0.904 | 0.668 | 1.22 | log | |
| Number needed to treat, for one fewer participant with the outcome on Intervention Group than on Control Group | 163 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Intervention Group | Patients included at all practices during practices' Labs intervention phase | 1,329 | 1,426 | OG001 |
| Group 2 | Control Group | Patients included at all practices during practices' Labs control phase | 1,273 | 1,357 | OG000 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Number of Patients With Abnormal Laboratory Results With Appropriate Actions Without Delay
- Description
Documented action step for first positive within 30 days:~1. Hemoglobin (Hgb) less than 11 and mean corpuscular volume (MCV) less than 75 in 1 or 2 year old without documentation of beginning iron, sending iron studies or family conversation~2. Lead greater than 5 without documentation of family conversation on lead remediation or plan to retest~Documented action step for first positive within 7 days:~1. Positive Gonorrhea, Chlamydia, Syphilis or Human immunodeficiency virus (HIV) test without documentation of antibiotics begun or referral to HIV specialist~2. Positive group A streptococcal throat culture with negative rapid group A streptococcal test without documentation of antibiotics begun or family conversation~3. Thyroid stimulating hormone (TSH) less than 0.5 or greater than 4.5 in greater than 1 year old without plan to repeat lab values or referral to endocrinologist
- Time frame
- Collected Monthly (5-9 baseline months and 8-9 intervention months depending on the enrolled cohort)
- Population
Source ClinicalTrials.gov
Trial
- Title
- Reducing Diagnostic Errors in Primary Care Pediatrics (Project RedDE)
- NCT number
- NCT02798354
- Phases
- NA
- Conditions
- Diagnostic Errors
- Interventions
- Quality Improvement Collaborative
- Lead sponsor
- Montefiore Medical Center
- Results first posted
- 2019-12-16
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02798354?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02798354-17b6241d